Ipsapirone
From Wikipedia, the free encyclopedia
 |
|
|
Ipsapirone
|
|
| Systematic (IUPAC) name | |
| 9,9-Dioxo-8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]- 9λ6-thia-8-azabicyclo[4.3.0]nona-1,3,5-trien-7-one |
|
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C19H23N5O3S |
| Mol. mass | 401.484 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Ipsapirone is an azapirone and partial 5-HT1A agonist that has anxiolytic effects.
[edit] References
- Fanelli R, Schuurman T, Glaser T, Traber J (1990). "Ipsapirone: a novel anxiolytic and selective 5-HT1A receptor ligand.". Prog Clin Biol Res 361: 461–7. PMID 1981264.
[edit] External links
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
